Read + Share
Amedeo Smart
Independent Medical Education
Chan M, Zhu S, Nukaya M, Ferreira LT, et al. DNAJ-PKAc fusion heightens PLK1 inhibitor sensitivity in fibrolamellar carcinoma. Gut 2025;74:1680-1693.PMID: 40274389
Email
LinkedIn
Privacy Policy